JP2010533178A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010533178A5 JP2010533178A5 JP2010516041A JP2010516041A JP2010533178A5 JP 2010533178 A5 JP2010533178 A5 JP 2010533178A5 JP 2010516041 A JP2010516041 A JP 2010516041A JP 2010516041 A JP2010516041 A JP 2010516041A JP 2010533178 A5 JP2010533178 A5 JP 2010533178A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- ligand
- acid molecules
- molecules encoding
- cationic liposome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92968507P | 2007-07-09 | 2007-07-09 | |
| US60/929,685 | 2007-07-09 | ||
| PCT/US2008/008394 WO2009009054A1 (en) | 2007-07-09 | 2008-07-09 | Methods for generating immune response using cationic-liposome-mediated nucleic acid delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014089131A Division JP2014148533A (ja) | 2007-07-09 | 2014-04-23 | カチオン性リポソーム媒介核酸送達を用いて免疫応答を引き起こす方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010533178A JP2010533178A (ja) | 2010-10-21 |
| JP2010533178A5 true JP2010533178A5 (enExample) | 2011-04-14 |
| JP5890095B2 JP5890095B2 (ja) | 2016-03-22 |
Family
ID=40228915
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010516041A Expired - Fee Related JP5890095B2 (ja) | 2007-07-09 | 2008-07-09 | カチオン性リポソーム媒介核酸送達を用いて免疫応答を引き起こす方法 |
| JP2014089131A Pending JP2014148533A (ja) | 2007-07-09 | 2014-04-23 | カチオン性リポソーム媒介核酸送達を用いて免疫応答を引き起こす方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014089131A Pending JP2014148533A (ja) | 2007-07-09 | 2014-04-23 | カチオン性リポソーム媒介核酸送達を用いて免疫応答を引き起こす方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20090053299A1 (enExample) |
| EP (1) | EP2175835B1 (enExample) |
| JP (2) | JP5890095B2 (enExample) |
| KR (2) | KR101570886B1 (enExample) |
| CN (2) | CN106890142A (enExample) |
| AU (1) | AU2008275713B2 (enExample) |
| BR (1) | BRPI0814558A2 (enExample) |
| CA (1) | CA2692546C (enExample) |
| EA (1) | EA201070050A1 (enExample) |
| IL (1) | IL203204B (enExample) |
| MX (1) | MX2010000166A (enExample) |
| NZ (1) | NZ582414A (enExample) |
| SG (1) | SG182994A1 (enExample) |
| WO (1) | WO2009009054A1 (enExample) |
| ZA (1) | ZA201000038B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5573111B2 (ja) * | 2009-11-06 | 2014-08-20 | ライオン株式会社 | イソプロピルメチルフェノール含有液体口腔用組成物 |
| US20110182976A1 (en) * | 2010-01-28 | 2011-07-28 | National Taiwan Ocean University | Lipoplex-patch based dna vaccine |
| US9028797B2 (en) | 2010-02-26 | 2015-05-12 | Nagasaki University | Composite body for antigen or drug delivery |
| RS63890B1 (sr) * | 2010-08-31 | 2023-02-28 | Glaxosmithkline Biologicals Sa | Mali lipozomi za isporuku rnk koja kodira imunogen |
| US8932575B2 (en) | 2010-09-21 | 2015-01-13 | University Of Miami | Compositions and methods for inducing migration by dendritic cells and an immune response |
| WO2012040266A2 (en) * | 2010-09-24 | 2012-03-29 | University Of Miami | Gene-based adjuvants and compositions thereof to increase antibody production in response to gene-based vaccines |
| US20140120157A1 (en) | 2012-09-19 | 2014-05-01 | Georgetown University | Targeted liposomes |
| AU2013200991B2 (en) * | 2012-09-19 | 2015-12-10 | Georgetown University | Targeted liposomes |
| CN103405386B (zh) * | 2012-09-21 | 2016-05-18 | 上海泽润生物科技有限公司 | 一种脂质体的制备方法及制作脂质体佐剂的方法 |
| WO2014159917A2 (en) | 2013-03-14 | 2014-10-02 | Georgetown University | Treatment for exposure to nerve agent |
| CN105726485B (zh) * | 2016-03-24 | 2019-08-06 | 东华大学 | 一种半乳糖化壳聚糖修饰的免疫醇质体的制备方法 |
| CA3121247A1 (en) | 2018-12-03 | 2020-06-11 | Board Of Regents, The University Of Texas System | Oligo-benzamide analogs and their use in cancer treatment |
| CN111840538A (zh) * | 2020-05-29 | 2020-10-30 | 中山大学 | 一种水痘-带状疱疹病毒亚单位纳米疫苗的制备方法和应用 |
| WO2022051023A1 (en) * | 2020-09-04 | 2022-03-10 | Infectious Disease Research Institute | Live-attenuated rna hybrid vaccine technology |
| CN117883382B (zh) * | 2023-11-27 | 2025-02-14 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 高效递送疫苗的脂质体载体及脂质体疫苗的制备与用途 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4957735A (en) * | 1984-06-12 | 1990-09-18 | The University Of Tennessee Research Corporation | Target-sensitive immunoliposomes- preparation and characterization |
| US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5688488A (en) * | 1989-04-03 | 1997-11-18 | Purdue Research Foundation | Composition and method for tumor imaging |
| US5753258A (en) * | 1990-10-19 | 1998-05-19 | University Of Florida | Artificial viral envelopes |
| US6099842A (en) * | 1990-12-03 | 2000-08-08 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant immunotoxin composed of a single chain antibody reacting with the human transferrin receptor and diptheria toxin |
| EP0671926B1 (en) * | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunomodulatory peptides |
| US5786214A (en) * | 1994-12-15 | 1998-07-28 | Spinal Cord Society | pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system |
| FR2730637B1 (fr) * | 1995-02-17 | 1997-03-28 | Rhone Poulenc Rorer Sa | Composition pharmaceutique contenant des acides nucleiques, et ses utilisations |
| WO1997000271A1 (en) * | 1995-06-14 | 1997-01-03 | The Regents Of The University Of California | Novel high affinity human antibodies to tumor antigens |
| US6210707B1 (en) * | 1996-11-12 | 2001-04-03 | The Regents Of The University Of California | Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| CA2271325A1 (en) * | 1996-11-12 | 1998-05-22 | The Regents Of The University Of California | Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery |
| US6794128B2 (en) * | 1998-04-24 | 2004-09-21 | The Regents Of The University Of California | Methods of selecting internalizing antibodies |
| US20030022854A1 (en) * | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
| AU3703100A (en) | 1999-02-22 | 2000-09-14 | Georgetown University | Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| US7780882B2 (en) | 1999-02-22 | 2010-08-24 | Georgetown University | Simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome for systemic administration of a therapeutic or diagnostic agent |
| US9034329B2 (en) * | 1999-02-22 | 2015-05-19 | Georgetown University | Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof |
| US20020103165A1 (en) * | 2000-02-29 | 2002-08-01 | Alliance Pharmaceutical Corp., | Engineered spray-dried lipid-based microparticles for cellular targeting |
| PL1633327T3 (pl) | 2003-06-04 | 2011-02-28 | Univ Georgetown | Sposób poprawienia stabilności i okresu trwałości kompleksów liposomowych |
| CA2638899C (en) * | 2005-10-20 | 2016-01-05 | Georgetown University | Tumor-targeted nanodelivery systems to improve early mri detection of cancer |
-
2008
- 2008-07-09 KR KR1020107002754A patent/KR101570886B1/ko not_active Expired - Fee Related
- 2008-07-09 NZ NZ582414A patent/NZ582414A/xx not_active IP Right Cessation
- 2008-07-09 BR BRPI0814558-0A2A patent/BRPI0814558A2/pt not_active Application Discontinuation
- 2008-07-09 EP EP08780044.7A patent/EP2175835B1/en active Active
- 2008-07-09 KR KR1020157025507A patent/KR20150108948A/ko not_active Withdrawn
- 2008-07-09 SG SG2012049664A patent/SG182994A1/en unknown
- 2008-07-09 JP JP2010516041A patent/JP5890095B2/ja not_active Expired - Fee Related
- 2008-07-09 CA CA2692546A patent/CA2692546C/en active Active
- 2008-07-09 AU AU2008275713A patent/AU2008275713B2/en not_active Ceased
- 2008-07-09 MX MX2010000166A patent/MX2010000166A/es active IP Right Grant
- 2008-07-09 US US12/216,715 patent/US20090053299A1/en not_active Abandoned
- 2008-07-09 CN CN201710070091.XA patent/CN106890142A/zh active Pending
- 2008-07-09 EA EA201070050A patent/EA201070050A1/ru unknown
- 2008-07-09 WO PCT/US2008/008394 patent/WO2009009054A1/en not_active Ceased
- 2008-07-09 CN CN200880105375A patent/CN101801344A/zh active Pending
-
2010
- 2010-01-04 ZA ZA2010/00038A patent/ZA201000038B/en unknown
- 2010-01-07 IL IL203204A patent/IL203204B/en active IP Right Grant
-
2014
- 2014-04-23 JP JP2014089131A patent/JP2014148533A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Recent advances in lipid nanoparticles and their safety concerns for mRNA delivery | |
| US12220455B2 (en) | Coronavirus vaccine compositions and methods | |
| Aldosari et al. | Lipid nanoparticles as delivery systems for RNA-based vaccines | |
| Meng et al. | Nanoplatforms for mRNA therapeutics | |
| Yuan et al. | mRNA nanodelivery systems: targeting strategies and administration routes | |
| JP2011516586A5 (enExample) | ||
| TWI434699B (zh) | 抗病毒藥劑之目標細胞內投遞 | |
| Tagami et al. | CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes | |
| CN102292069B (zh) | 囊泡制剂 | |
| WO2020069718A1 (en) | Rna particles comprising polysarcosine | |
| EP4268808A1 (en) | Lipid nanoparticles comprising mannose or uses thereof | |
| Zhang et al. | Hybrids of nonviral vectors for gene delivery | |
| CN107849567A (zh) | 一种siRNA、含有该siRNA的药物组合物和缀合物及它们的应用 | |
| NZ588583A (en) | Novel lipid formulations for nucleic acid delivery | |
| CN101801344A (zh) | 关于使用阳离子脂质体介导的核酸递送产生免疫应答的方法 | |
| EP4262761A4 (en) | TISSUE-SPECIFIC NUCLEIC ACID DELIVERY BY 1,2-DIOLEOYL-3-TRIMETHYLAMMONIUM PROPANE (DOTAP) LIPID DNANOPARTICLES | |
| CN119074950A (zh) | 一种增强mRNA-LNP组织靶向递送的方法 | |
| Jallow et al. | Versatility of LNPs across different administration routes for targeted RNA delivery | |
| C Silva et al. | Delivery systems for biopharmaceuticals. Part II: liposomes, micelles, microemulsions and dendrimers | |
| KR20240083166A (ko) | 폐를 표적장기로 하는 생분해성 지질나노입자 약물 전달 제형 및 이의 활용 | |
| TW202608429A (zh) | 用於核酸之靶向運送之脂質奈米遞送粒子及其製備及使用方法 | |
| TW202345860A (zh) | 核酸-脂質奈米粒子及使用其之方法 | |
| TW202539711A (zh) | 靶向抗原呈遞細胞的脂質組合物及其應用 | |
| CN116615233A (zh) | 用于使生物分子在受试者中表达的系统和方法 | |
| US10668172B2 (en) | Treatment for exposure to nerve agent |